InsidersTradesSigma
Follow the Xbrane Biopharma AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Xbrane Biopharma AB has logged 5 public disclosures. Market capitalisation: €222.5m. The latest transaction was reported on 28 October 2025 (Sale). Among the most active insiders: Siavash Bashiri. All data is free.
5
Insider Decl.
n/a
Thresholds
€42,715
4 ops.
Buy Volume
€4,647
1 ops.
Sell Volume
35Σ signal
Fundamental score
Ranked 11,669 of 28,932 companies
56.8
score / 100
Value50
Quality64
FCF yld-187%
Earn yld61%
EV/EBITDA·
ROE-16%
Gross mgn59%
Net mgn83%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 October 2025
Declarations5 total
4,976 shares@ €0.93380.0020% mcap100.0% of flowAktieISIN SE0026598583FI:A003T195-1
1,500 shares@ SEK 82.54100.0% of flowAktieISIN SE0007789409FI:A001P657-1
750 shares@ SEK 76.20100.0% of flowAktieISIN SE0007789409FI:A001P598-1
2,000 shares@ SEK 78.40100.0% of flowAktieISIN SE0007789409FI:A001P565-1
1,150 shares@ SEK 81.60100.0% of flowAktieISIN SE0007789409FI:A001P393-1
5 of 5 declarations
About Xbrane Biopharma AB
Xbrane Biopharma AB is a biopharmaceutical company focused on the development of biosimilars. It is listed on the XSTO market.